ABOS
Acumen Pharmaceuticals, Inc.- Last price
- $2.63
- As of
Active signals for ABOS
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 28.5% — EPS $-0.44 vs $-0.6157 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 23.9% — EPS $-0.68 vs $-0.5488 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 19.7% — EPS $-0.33 vs $-0.4108 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 11.3% — EPS $-0.41 vs $-0.4622 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 23.9% — EPS $-0.68 vs $-0.5488 estimate
Top institutional holders of ABOS (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $1.6M | 0.00% | +12.9% |
| TWO SIGMA INVESTMENTS, LP | $1.3M | 0.00% | +270.6% |
| MILLENNIUM MANAGEMENT LLC | $1.2M | 0.00% | -2.9% |
| RENAISSANCE TECHNOLOGIES LLC | $1.1M | 0.00% | +12.0% |
| MILLENNIUM MANAGEMENT LLC | $1M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLC | $999K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLC | $893K | 0.00% | -27.6% |
| CITADEL ADVISORS LLC | $845K | 0.00% | , |
| CITADEL ADVISORS LLC | $729K | 0.00% | -30.1% |
| TWO SIGMA INVESTMENTS, LP | $341K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $302K | 0.00% | -28.2% |
| Point72 Asset Management, L.P. | $159K | 0.00% | +85.3% |
| Point72 Asset Management, L.P. | $77K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, ABOS
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Related tickers
See more ABOS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track ABOS in your watchlist and get notified the moment a new signal fires.
Track ABOS on Kresmion →